Kyowa Kirin Reports Final German MINT Study Results for Mogamulizumab
Kyowa Kirin International announced final results from the German MINT study evaluating mogamulizumab in patients with mycosis fungoides and Sézary syndrome.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.